Evotec SE Accounts Payable

Evotec SE (EVO) currently reports a accounts payable of $55M as of March 2026. That compares with $61M in the prior-year period — down 10.3% year over year. Use the charts on this page to explore Evotec SE's accounts payable history and peer comparisons.

Evotec SE's accounts payable decreased from $61M to $55M — a 10.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evotec SE reported $55M in accounts payable as of March 2026. That compares with $61M in the prior-year period — down 10.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $55M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evotec SE, and consider following EVO for alerts when major investors trade the stock.

Evotec SE is classified in the Healthcare sector. On accounts payable, it currently shows $55M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVO with unrelated industries.